Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ivan Fan Ngai Hung

Has grant

Chair Professor

The University of Hong Kong

Hong Kong

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Microbiology

Recent Grants

Grant: Close

Intradermal Quadrivalent Influenza Vaccine with Topical Imiquimod in Elderly & Chronic Illness Subjects, a Double-Blind Randomized Controlled Trial

Open Date: 2019-01-01

Close Date:

Grant: Close

A double-blind, randomised, controlled trial on flufenamic acid, clarithromycin and oseltamivir combination for hospitalized influenza infection

Open Date: 2019-01-01

Close Date:

Grant: Close

Immunogenicity of intradermal quadrivalent influenza and 13-valent pneumococcal conjugated vaccination with topical imiquimod in at risk individuals

Open Date: 2015-01-01

Close Date:

Grant: Close

A double blind randomized controlled trial of intradermal hepatitis B vaccination with topical imiquimod in dialyzed patients with chronic renal failure

Open Date: 2014-01-01

Close Date:

Grant: Close

A double-blind randomized controlled trial of 13-valent pneumococcal conjugated vaccine in patients with chronic illness

Open Date: 2014-01-01

Close Date:

Articles (18)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

Clinical Assistant Professor

The University of Hong Kong

HONG KONG

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ivan Fan Ngai Hung

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (18)

Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities

Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024

Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation study

Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options

Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study

Aptamer-Mediated Electrochemical Detection of SARS-CoV-2 Nucleocapsid Protein in Saliva

Baseline Gut Microbiota Was Associated with Long-Term Immune Response at One Year Following Three Doses of BNT162b2

Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro

Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study

Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac

The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac

Epidemiology and Outcomes of Hypernatraemia in Patients with COVID-19—A Territory-Wide Study in Hong Kong

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C–C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation

Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort

A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID

Collaborators (10)

Ting-Fung Ma

Cheuk Chun Szeto

VITTORIO SAMBRI

Andrew Kinghorn

Jack KC Ng

Hui Zhang

Susanna Esposito

Kelvin To

Siddharth Sridhar

King-Pui Florence Chan

Make your next move.